NIAID Panels Review Grants for Disease Research Funding
Published Date: 7/17/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding public and private meetings on September 25, 2025, to review grant applications and share important updates. Scientists, researchers, and grant applicants will be affected as funding decisions and reports from top leaders are discussed. The open sessions will be streamed online, making it easy for anyone interested to tune in and stay informed.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 0 costs, 1 mixed.
NIAID to Review Grant Applications
If you are a scientist, researcher, or grant applicant, NIAID will hold closed sessions on September 25, 2025 from 8:30 a.m. to 10:30 a.m. to review and evaluate grant applications; funding decisions and application discussions will occur during that time.
Open Sessions Videocast for Public
You can watch the NIAID open sessions online: on September 25, 2025 the Council open session is scheduled 10:30 a.m. to 11:45 a.m., and several subcommittee open sessions run 1:00 p.m. to mid- or late-afternoon; the open sessions will be videocast at http://videocast.nih.gov.
Closed Sessions Protect Confidential Information
NIAID will close portions of the meetings (per 5 U.S.C. 552b(c)(4) and (c)(6)) because grant discussions could disclose confidential trade secrets, patentable material, or personal information; those sensitive details will not be public.
Accommodations Available for Attendees
If you plan to attend and need special assistance (for example, sign language interpretation), you should notify the contact person (Kelly Y. Poe, Ph.D., (240) 669-5036 or [email protected]) in advance of the September 25, 2025 meeting so reasonable accommodations can be arranged.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
Previous / Next Documents
Previous: 2025-13434 — National Institute of Allergy and Infectious Diseases; Notice of Meeting
The National Institute of Allergy and Infectious Diseases is holding a public meeting on September 25, 2025, to discuss the latest updates on AIDS research. Anyone interested can watch online, and special accommodations are available if requested ahead of time. This meeting helps guide important health research and keeps the public in the loop without any cost to attend.
Next: 2025-13436 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding two closed virtual meetings in August 2025 to review important grant applications in neuroscience and transplant immunology. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants should note the dates and prepare, as these reviews impact funding decisions.